N, A., PW, M., MB, S., JS, S., J, C., H, S., & TR, H. (2023). Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment. Current oncology reports, 25(10), 1127. https://doi.org/10.1007/s11912-023-01438-w
Chicago Style (17th ed.) CitationN, Andreatos, McGarrah PW, Sonbol MB, Starr JS, Capdevila J, Sorbye H, and Halfdanarson TR. "Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment." Current Oncology Reports 25, no. 10 (2023): 1127. https://doi.org/10.1007/s11912-023-01438-w.
MLA (9th ed.) CitationN, Andreatos, et al. "Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment." Current Oncology Reports, vol. 25, no. 10, 2023, p. 1127, https://doi.org/10.1007/s11912-023-01438-w.